- Filed
- Oct 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Sep 30, 2025 | 1.26B sh |
| Shares Diluted | Q1 2026 · Aug 31, 2025 | 1.25B sh |
| Shares Diluted | Q1 2026 · Aug 31, 2024 | 1.2B sh |
| Operating Cash Flow | Q1 2026 · Aug 31, 2025 | −$2.45M |
| Operating Cash Flow | Q1 2026 · Aug 31, 2024 | $5.44M |
| Cash And Equivalents | Q1 2026 · Aug 31, 2025 | $9.33M |
| Cash And Equivalents | Q1 2026 · May 31, 2025 | $11.9M |
| Stockholders Equity | Q1 2026 · Aug 31, 2025 | −$99.51M |
| Stockholders Equity | Q1 2026 · May 31, 2025 | −$96.04M |
| Stockholders Equity | Q1 2026 · Aug 31, 2024 | −$85.21M |
| Stockholders Equity | Q1 2026 · May 31, 2024 | −$116.76M |
| Current Liabilities | Q1 2026 · Aug 31, 2025 | $69.42M |
| Current Liabilities | Q1 2026 · May 31, 2025 | $70.52M |
| Total Liabilities | Q1 2026 · Aug 31, 2025 | $112.99M |
| Total Liabilities | Q1 2026 · May 31, 2025 | $114.09M |
| Current Assets | Q1 2026 · Aug 31, 2025 | $13.35M |
| Current Assets | Q1 2026 · May 31, 2025 | $17.88M |
| Total Assets | Q1 2026 · Aug 31, 2025 | $13.48M |
| Total Assets | Q1 2026 · May 31, 2025 | $18.05M |
| Eps Diluted | Q1 2026 · Aug 31, 2025 | $0.00 |
| Eps Diluted | Q1 2026 · Aug 31, 2024 | $0.02 |
| Eps Basic | Q1 2026 · Aug 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Aug 31, 2024 | $0.02 |
| Sga Expense | Q1 2026 · Aug 31, 2025 | $1.71M |
| Sga Expense restated | Q1 2026 · Aug 31, 2024 | $1.61M |
| Net Income | Q1 2026 · Aug 31, 2025 | −$5.54M |
| Net Income | Q1 2026 · Aug 31, 2024 | $19.23M |
| Operating Income | Q1 2026 · Aug 31, 2025 | −$4.95M |
| Operating Income | Q1 2026 · Aug 31, 2024 | $22.44M |